Quantitative MRI can detect subclinical disease progression in muscular dystrophy.

Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D.
J Neurol. 2012. 259(8): 1648-54.
The aim of this study was to compare different methods of quantitative and semiquantitative MRI in order to validate clinical parameters for the follow-u of Oculopharyngeal muscular dystrophy (OPMD).
MRI results were compared to MFM results.

PubMed link

Keywords: MRI, Neuromuscular disease, OPMD, Follow-up

Articles dans les revues scientifiques

Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.

D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res. 2012. 65(4): 472-9. The main of this monocentric pilot study was to evaluate...

read more